We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02228213
Recruitment Status : Completed
First Posted : August 28, 2014
Last Update Posted : July 14, 2017
Syneos Health
Information provided by (Responsible Party):
Innate Immunotherapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2017
Actual Study Completion Date : June 2017